[HTML] nih.gov

[HTML][HTML] 2, 5-dimethylcelecoxib alleviated NK and T-cell exhaustion in hepatocellular carcinoma via the gastrointestinal microbiota-AMPK-mTOR axis

B Pan, Z Chen, X Zhang, Z Wang, Y Yao… - … for immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Background 2, 5-dimethylcelecoxib (DMC), a derivative of celecoxib, is an inhibitor of
microsomal prostaglandin E synthase-1 (mPGES-1). Our previous studies have …
被引用次数：15 相关文章

2, 5-dimethylcelecoxib alleviated NK and T-cell exhaustion in hepatocellular carcinoma via the gastrointestinal microbiota-AMPK-mTOR axis

B Pan, Z Chen, X Zhang, Z Wang… - Journal for …, 2023 - pubmed.ncbi.nlm.nih.gov
Background 2, 5-dimethylcelecoxib (DMC), a derivative of celecoxib, is an inhibitor of
microsomal prostaglandin E synthase-1 (mPGES-1). Our previous studies have …

2, 5-dimethylcelecoxib alleviated NK and T-cell exhaustion in hepatocellular carcinoma via the gastrointestinal microbiota-AMPK-mTOR axis.

B Pan, Z Chen, X Zhang, Z Wang, Y Yao… - … for Immunotherapy of …, 2023 - europepmc.org
Background 2, 5-dimethylcelecoxib (DMC), a derivative of celecoxib, is an inhibitor of
microsomal prostaglandin E synthase-1 (mPGES-1). Our previous studies have …
[HTML] bmj.com

[HTML][HTML] 2, 5-dimethylcelecoxib alleviated NK and T-cell exhaustion in hepatocellular carcinoma via the gastrointestinal microbiota-AMPK-mTOR axis

B Pan, Z Chen, X Zhang, Z Wang, Y Yao… - … for ImmunoTherapy of …, 2023 - jitc.bmj.com
Background 2, 5-dimethylcelecoxib (DMC), a derivative of celecoxib, is an inhibitor of
microsomal prostaglandin E synthase-1 (mPGES-1). Our previous studies have …

2, 5-dimethylcelecoxib alleviated NK and T-cell exhaustion in hepatocellular carcinoma via the gastrointestinal microbiota-AMPK-mTOR axis

B Pan, Z Chen, X Zhang, Z Wang, Y Yao… - Journal for …, 2023 - search.proquest.com
Background 2, 5-dimethylcelecoxib (DMC), a derivative of celecoxib, is an inhibitor of
microsomal prostaglandin E synthase-1 (mPGES-1). Our previous studies have …

2, 5-dimethylcelecoxib alleviated NK and T-cell exhaustion in hepatocellular carcinoma via the gastrointestinal microbiota-AMPK-mTOR axis.

B Pan, Z Chen, X Zhang, Z Wang, Y Yao… - … for Immunotherapy of …, 2023 - europepmc.org
Background 2, 5-dimethylcelecoxib (DMC), a derivative of celecoxib, is an inhibitor of
microsomal prostaglandin E synthase-1 (mPGES-1). Our previous studies have …